US2003055215A1PendingUtilityA1
Novel calcium-binding proteins
Est. expiryMar 6, 2015(expired)· nominal 20-yr term from priority
C07K 16/18C07K 14/4728
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A bovine- or human-derived calcium-binding protein with a prescribed amino acid sequence, a method for its production, and antibodies against the protein and uses thereof.
Claims
exact text as granted — not AI-modified1 . A calcium-binding protein comprising an amino acid sequence which is substantially identical to the amino acid sequence listed in SEQ ID NO: 1 or 12.
2 . The calcium-binding protein CAAF1 consisting of the amino acid sequence listed in SEQ ID NO: 1 or 12.
3 . A protein or peptide which is a portion of a protein according to claim 1 .
4 . A fused protein comprising a protein or peptide according to claim 1 and another protein or peptide.
5 . DNA encoding a protein according to claim 1 .
6 . DNA capable of being hybridized with DNA having the nucleotide sequence listed in SEQ ID NO: 1 or 12, and encoding a protein with calcium-binding activity.
7 . A recombinant DNA molecule comprising DNA according to claim 5 which is linked to a gene regulating factor.
8 . A recombinant DNA molecule according to claim 7 , wherein said gene regulating factor is a prokaryotic promoter system or eukaryotic expression regulator system.
9 . An expression vector comprising a recombinant DNA molecule according to claim 7 .
10 . Recombinant host cells which have been transformed with an expression vector according to claim 9:
11 . Recombinant host cells according to claim 10 , wherein the host cells are eukaryotic cells or prokaryotic cells.
12 . Recombinant host cells according to claim 11 , wherein the prokaryotic cells are bacterial cells.
13 . Recombinant host cells according to claim 12 , wherein said bacterial cells are of Escherichia coli.
14 . Recombinant host cells according to claim 11 , wherein said the eukaryotic cells are of yeast or filamentous fungus.
15 . Recombinant host cells according to claim 11 , wherein said eukaryotic cells are plant cells or animal cells.
16 . A method for producing a calcium-binding protein according to claim 2 , characterized by isolating said protein from bovine amniotic fluid or bovine tissue, or a human tissue.
17 . A method for producing a protein according to claim 1 , characterized by culturing host cells transformed with an expression vector comprising DNA encoding said protein, and collecting said protein from the culture.
18 . An antibody with binding affinity to a protein according to claim 1 .
19 . An antibody according to claim 18 , which is a polyclonal antibody or monoclonal antibody.
20 . A hybridoma which produces a monoclonal antibody according to claim 19 .
21 . A method for producing a monoclonal antibody with binding affinity to a calcium-binding protein, characterized by culturing a hybridoma producing said monoclonal antibody.
22 . A diagnostic agent for inflammatory diseases, neoplastic diseases (especially squamous epithelial carcinoma), dermatosis or blood diseases, which comprises an antibody according to claim 18 .
23 . A calcium-binding protein assay reagent comprising an antibody according to claim 18 .
24 . An assay method for a calcium-binding protein, characterized by using a reagent according to claim 23.Join the waitlist — get patent alerts
Track US2003055215A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.